Reassessing medical risk in living kidney donors
- PMID: 25255922
- PMCID: PMC4413760
- DOI: 10.1681/ASN.2014030227
Reassessing medical risk in living kidney donors
Abstract
The short- and long-term effects of unilateral nephrectomy on living donors have been important considerations for 60 years. Short-term risk is well established (0.03% mortality and <1% risk of major morbidity), but characterization of long-term risk is evolving. Relative to the general population, risk of mortality, ESRD, hypertension, proteinuria, and cardiovascular disease is comparable or lower. However, new studies comparing previous donors with equally healthy controls indicate increased risk of metabolic derangements (particularly involving calcium homeostasis), renal failure, and possibly, mortality. We discuss how these results should be interpreted and their influence on the practice of living donor kidney transplantation.
Keywords: ESRD; kidney transplantation; living donor; mortality risk.
Copyright © 2015 by the American Society of Nephrology.
References
-
- Schold JD, Meier-Kriesche H-U: Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis? Clin J Am Soc Nephrol 1: 532–538, 2006 - PubMed
-
- Murray JE: Surgery of the Soul: Reflections on a Curious Career, Canton, MA, Science History Publications, 2001
-
- Flanigan WJ, Burns RO, Takacs FJ, Merrill JP: Serial studies of glomerular filtration rate and renal plasma flow in kidney transplant donors, identical twins, and allograft recipients. Am J Surg 116: 788–794, 1968 - PubMed
-
- Fehrman-Ekholm I, Elinder CG, Stenbeck M, Tydén G, Groth CG: Kidney donors live longer. Transplantation 64: 976–978, 1997 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical